OMEPRAZOLE 20 MG
OMEPRAZOLE : 20 MG · DIN 02348691 · SANIS HEALTH INC
Health Canada status: MARKETED
What is OMEPRAZOLE?
OMEPRAZOLE 20 MG contains OMEPRAZOLE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02348691, held by SANIS HEALTH INC, supplied as CAPSULE (DELAYED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Dec-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is OMEPRAZOLE used for?
Treatment of duodenal ulcer, gastric ulcer, NSAID-associated ulcers, reflux esophagitis, symptomatic GERD, Zollinger-Ellison syndrome, and eradication of Helicobacter pylori.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02348691 |
|---|---|
| Brand name | OMEPRAZOLE |
| Generic / active ingredient | OMEPRAZOLE : 20 MG |
| Manufacturer | SANIS HEALTH INC |
| Strength | 20 MG |
| Dosage form | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A02BC01 OMEPRAZOLE |
| AHFS class | 56:28.36 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Dec-2016 |
| Original market date | 2010-06-16 00:00:00 |
How is it administered?
Adults: 20 mg once daily for most indications (ulcers, GERD, esophagitis). Zollinger-Ellison: initial 60 mg daily. H. pylori: 20 mg twice daily with antibiotics. Swallow whole; do not chew/crush.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text snippet (refer to section 11), but generally requires protection from moisture.
How is it supplied?
Available in bottles of 500 capsules.
Contraindications
Hypersensitivity to omeprazole, substituted benzimidazoles, or any ingredient. Co-administration with rilpivirine.
Warnings and precautions
Exclude malignancy before treatment. Risk of Clostridium difficile-associated diarrhea, bone fracture (long-term/high-dose), hypomagnesemia, and acute tubulointerstitial nephritis.
What can be used instead?
Other Canadian products sharing ATC code A02BC01 OMEPRAZOLE. 12 of 57 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-OMEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | ACCORD HEALTHCARE INC | MARKETED | DIN 02416549 |
| APO-OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02245058 |
| BIO-OMEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | BIOMED PHARMA | MARKETED | DIN 02449927 |
| HEARTBURN CONTROL | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02435683 |
| JAMP-OMEPRAZOLE DR | 20 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02420198 |
| LOSEC | 20 MG | CAPSULE (DELAYED RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 00846503 |
| LOSEC MUPS | 20 MG | TABLET (DELAYED-RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02242462 |
| OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02339927 |
| OMEPRAZOLE-20 | 20 MG | CAPSULE (DELAYED RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02411857 |
| TEVA-OMEPRAZOLE | 10 MG | TABLET (DELAYED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02295407 |
Who else supplies OMEPRAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OMEPRAZOLE appears in 1096 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.